Oral Presentations

By Rosalyn Año, BME


By John Iannone, BME


By Judith Newmark, PhD


By John Iannone, BME, Anja Cerstiaens, PhD, and Karen Pieters, Ir.


By John Iannone, BME


By Michael Brady, PhD and John Iannone, BME


By Stephen Doherty, PhD


By John Iannone, BME


By Stephen Doherty, PhD


By Judith Newmark, PhD


By Curtis Schondelmeyer, DVM


By John Iannone, BME and Michael Ruberto, PhD

Don't see what you are looking for? Submit the form below.

Preclinical CRO | Preclinical Development Services
toxicology (acute, subchronic, and chronic toxicity, reproductive toxicity, genetic toxicology, and carcinogenicity), pharmacokinetics, toxicokinetics, bioavailability, ADME, chemical characterization, impurities analysis and synthesis, bioanalytical, and microbiology/virology, pharmaceutical, medical device, or biotech company, anticancer or antiviral compound, ocular studies, ophthalmic, disease models, Analytical and Bioanalytical Chemistry, Biocompatibility Assessment, biocompatibility Safety Evaluation Guidelines, Cell and Molecular Biology, Disease Models, Efficacy and Surgical Research Services, Extractables and Leachables, microbiology, Ocular Drug Program, Pathology, R&D and Discovery
Toxikon is a preclinical contract research organization (CRO) dedicated to collaborating with biotech, pharmaceutical and medical device researchers to deliver exceptional drug research and development services from concept to final product.